✦ LIBER ✦

Pharmacokinetics of the dopamine D2 agonist S(-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in freely moving rats

✍ Scribed by P. J. Swart; R. A. de Zeeuw

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 503 KB
Volume: 82
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.2600820217

No coin nor oath required. For personal study only.

✦ Synopsis

The pharmacokinetics of the dopamine D2 agonist S( -)-2-(N-propyl-N2-thienylethylamino)-5-hydroxytetralin (1, N-0923) after intravenous, intraperitoneal, and oral administration was studied in freely moving male and female albino Wistar rats. In all cases, the dose was

📜 SIMILAR VOLUMES

Pharmacokinetic study of (S)-(−)-2-(N-pr

Pharmacokinetic study of (S)-(−)-2-(N-propyl-N-(2-thienylethyl)amino)-5-hydroxytetralin infusion in cynomolgus monkeys

✍ Denise R. Lowe Walters; William R. McConnell; Eugenio A. Cefali 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

A pharmacokinetic study of the dopamine 0 2 receptor agonist ( S)-(-)-2-(Npropyl-N(2-thienylethyl)amino)-5-hydroxytetralimHCl (K0923) infused in female cynomolgus monkeys over a 4-h period was carried out at International Research and Development Corporation. The purpose of this study was to estimat

Characterization of the dopamine D3 rece

Characterization of the dopamine D3 receptor agonist R(+)-7-hydroxy-N, N-di-n-propyl-2-aminotetralin-induced hypo- and hypermotility in mice

✍ Makoto Ukai; Hiroko Tamoto; Tomoko Tanaka; Tsutomu Kameyama 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

The present study was designed to characterize the dopamine D 3 receptor agonist R()-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (R()-7-OH-DPAT)-induced changes in locomotor activity in mice. Although R()-7-OH-DPAT (0 . 01±10 mg/kg) produced a signi®cant decrease in horizontal and vertical motility wi

N-0923, a selective dopamine D2 receptor

N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease

✍ Dr. J. D. Belluzzi; E. F. Domino; J. M. May; K. S. Bankiewicz; D. A. McAfee 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 800 KB

## Abstract Certain aminotetralins are known to be potent dopamine D~2~ receptor agonists. N‐0923, [‐]2‐(N‐propyl‐N‐2‐thienylethylamino)‐5‐hydroxytetralin HCl, recognizes the high and low affinity states of the D~2~ receptor in membranes from bovine caudate with a K~low~ of 79 nM. The selectivity r

In vitro and in vivo evaluation of the b

In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist 11C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate

✍ Jogeshwar Mukherjee; Tanjore K. Narayanan; Bradley T. Christian; Bingzhi Shi; Ke 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 3 views

The in vitro autoradiographic binding characteristics as well as in vivo imaging characteristics of a dopamine D2 receptor agonist, (R,S)-2-(N-propyl-N-1Ј-11 Cpropyl)amino-5-hydroxytetralin ( 11 C-5-OH-DPAT), were studied. In 3 H-spiperone assays using rat striata, 5-OH-DPAT exhibited an affinity of